CRSP logo

CRISPR Therapeutics AG (CRSP) Enterprise value

Enterprise value:

$4.02B+$106.23M(+2.71%)
June 24, 2025

Summary

  • As of today (June 25, 2025), CRSP enterprise value is $4.02 billion, with a rise of +$106.23 million (+2.71%) during the most recent trading session on June 24, 2025.
  • Over the past year, CRSP enterprise value has dropped by -$305.35 million (-7.05%).
  • CRSP enterprise value is now -72.09% below its all-time high of $14.42 billion.

Performance

CRSP Enterprise value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherCRSPvaluation metrics

Enterprise value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

CRSP Enterprise value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday+2.7%+2.7%+2.7%
1 m1 month+27.1%+26.9%+26.9%
3 m3 months-+10.0%+9.8%
6 m6 months+15.1%+15.6%+14.3%
ytdytd+22.0%+19.8%+18.9%
1 y1 year-7.0%-15.9%-19.3%
5 y5 years+9.1%-10.8%-36.0%

CRSP Enterprise value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month$4.02Bat high$3.12B+29.1%
3 m3-month$4.02Bat high$2.85B+41.3%
6 m6-month$4.47B-10.0%$2.85B+41.3%
1 y1-year$5.12B-21.4%$2.85B+41.3%
3 y3-year$7.36B-45.4%$2.79B+44.0%
5 y5-year$14.42B-72.1%$2.79B+44.0%
alltimeall time$14.42B-72.1%$256M+1472.6%

CRSP Enterprise value History

DateValue
2025
$4.02B(+22.0%)
2024
$3.30B(-32.3%)
2023
$4.88B(+47.2%)
2022
$3.31B(-35.5%)
2021
$5.14B(-49.7%)
DateValue
2020
$10.21B(+263.2%)
2019
$2.81B(+174.3%)
2018
$1.02B(+43.7%)
2017
$713.35M(+45.8%)
2016
$489.20M

FAQ

  • What is CRISPR Therapeutics AG enterprise value?
  • What is the all time high enterprise value for CRISPR Therapeutics AG?
  • What is CRSP enterprise value year-to-date change?
  • What is CRISPR Therapeutics AG enterprise value year-on-year change?

What is CRISPR Therapeutics AG enterprise value?

The current enterprise value of CRSP is $4.02B

What is the all time high enterprise value for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high enterprise value is $14.42B

What is CRSP enterprise value year-to-date change?

CRISPR Therapeutics AG enterprise value has changed by +$725.74M (+22.00%) since the beginning of the year

What is CRISPR Therapeutics AG enterprise value year-on-year change?

Over the past year, CRSP enterprise value has changed by -$305.35M (-7.05%)
On this page